Novartis Discontinued Clinical Trial Program For ASA404
“Novartis (NYSE:NVS) discontinued its ASA404 clinical trial program after it failed to meet a primary endpoint. Interim results from a Phase III trial show that the drug failed to meet the primary endpoint of extending survival for the second-line treatment of non-small cell lung cancer. Related impairment charges of about 0 million will be taken in Q4. Novartis has a potential upside of 14.7% based on a current price of .8 and an average consensus analyst price target of .15.”
Video Rating: 5 / 5
JVZoo Product Feed
GRACEcast-100_Lung-Cancer_MM in LC Pt 5: Dr. Spigel on Incorporating Targets into Clinical Trials
cancerGRACE.org Dr. David Spigel, Sarah Cannon Cancer Center, discusses the benefits and challenges of conducting trials that include patient subgroups based on molecular markers.
JVZoo Product Feed
Categories: Videos Tags: spigel, trials, clinical, targets, into, gracecast100_lungcancer_mm, incorporating
Video game chips used in US clinical trial for cancer
Computer graphics chips are the powerful computer cards that allow us to see what is happening on our computer screens. But now, the powerful cards are also being used to help rapidly process pictures of cancer tumours – a possibility not previously available. This advancement is now speeding treatment plans for cancer patients as well. Al Jazeera’s Stefanie Dekker reports.
Video Rating: 4 / 5
Indiegogo: www.indiegogo.com Tumblr: dtbp.tumblr.com Facebook Page: facebook.com/dtbpath Twitter: @DiscoverThePath Discovering The Beating Path: This documentary will explore what the cancer community offers, whether it is camps, support, and or success stories. It will follow two cancer survivors as they embark on a journey across the West. It will be a road trip from Chicago to California and back. On the road they will be couch surfing, and documenting all the new experiences they encounter. They will show how the cancer camps provide a positive environment, and that everyone has loving heart. The success stories will provide hope, and inspiration to all. By going to camps, and talking to survivors will show that there is a life after treatment. * Original Score by: Vince Ortegon
JVZoo Product Feed
Dr. West Talks About Anticipated Future Clinical Trials
H. Jack West, MD, medical director of the Thoracic Oncology Program at the Swedish Cancer Institute in Seattle, Washington, explains his anticipation to see an overall survival benefit emerge from the PARAMOUNT study examining continuation maintenance with pemetrexed in non-small cell lung cancer. He mentions a strong interest in clinical trials examining next generation studies such as crizotinib in patients that do not have the ALK rearrangement and BRAF targeted therapies which are still in their infancy.
Video Rating: 0 / 5
JVZoo Product Feed
How to Participate in a Mesothelioma Clinical Trial
www.mesotheliomaattorneyfreeconsultation.com Francisco Rodriguez About the Author Do You Need a Mesothelioma Lawyer? Permission is hereby granted to reprint this article as long as proper credit is given including the information and links.
Video Rating: 0 / 5
JVZoo Product Feed
Categories: Videos Tags: participate, trial, clinical, mesothelioma
Find a Clinical Trial: Part One of Two
The NCI Clinical Trials Search Form (www.cancer.gov allows you to search a list of more than 8000 clinical trials now accepting participants, as well as a longer list of trials no longer recruiting. This video is Part One: How to use the search form to find cancer clinical trials that you or a loved one might be eligible to join. For additional guidance, see “Help Using the NCI Clinical Trials Search Form” (www.cancer.gov
Video Rating: 0 / 5
JVZoo Product Feed
Clinical implications of the biomarker analysis: TORCH trial – European Lung Cancer Conference 2012
Dr Mok highlights the strong value of EGFR mutation status when selecting the most effective treatment sequence in advanced NSCLC Abstract 163O Biomarkers of TORCH Trial on First-line Erlotinib Followed by Second-line Chemotherapy in Advanced Non-Small Cell Lung Cancer Patients MS Tsao1, C. Gallo2, M. Saieg1, GDC Santos1, V. Gebbia3, F. Perrone2, C. Butts4, F. Ciardiello2, R. Feld5, C. Gridelli6 1Toronto/CA, 2Napoli/IT, 3Palermo/IT, 4Edmonton, AB/CA, 5Toronto, ON/CA, 6Avellino/IT
JVZoo Product Feed
Categories: Videos Tags: clinical, conference, lung, torch, implications, biomarker, 2012, trial, european, analysis
Dr. West Explains the Pemetrexed Clinical Trial
H. Jack West, MD, medical director of the Thoracic Oncology Program at the Swedish Cancer Institute in Seattle, Washington, describes progression free survival (PFS) for patients with advanced nonsquamous non–small cell lung cancer (NSCLC) in the PARAMOUNT phase III trial examining continuation maintenance therapy in two randomized arms; one receiving pemetrexed in addition to best supportive care and the other placebo and best supportive care.
Video Rating: 0 / 5
JVZoo Product Feed
Emphysema Clinical Trials – Franklin Square Hospital Center
Clinical trials are leading to new treatments and interventions… Visit: www.franklinsquare.org
Video Rating: 0 / 5
Christopher Drake explains how Buteyko’s Method reverses the symptoms of emphysema and COPD
Video Rating: 5 / 5
JVZoo Product Feed
Participating In Cancer Clinical Trials: Part 1 – What You Need To Know
Part 1 of a National Cancer Institute cancer clinical trials educational video created for people who are considering participation in a trial. The video explains and answers common questions about the types of clinical trials, how they are conducted, and factors to think about when deciding whether or not to participate in a trial. The video also features actual patients who share their reasons and decisions about participating in cancer clinical trials. View Part 2 of this video: www.youtube.com To order the entire Understanding Cancer Clinical Trials DVD and other free clinical trial educational materials, call NCI’s Cancer Information Service at 1-800-4-CANCER (1-800-422-6237) or visit www.cancer.gov . You can find additional information about clinical trials online at www.cancer.gov NCI’s Cancer Information Service is also available to answer other questions you may have: 1-800-422-6237 For Copyright Notice and Restrictions please visit our Web site at www.cancer.gov
Video Rating: 5 / 5
JVZoo Product Feed
Dr Paz-Ares Discusses Pemetrexed Clinical Trial
Luis Paz-Ares, MD, PhD from Seville University Hospital in Spain Discusses the Pemetrexed Advanced Nonsquamous Non–Small Cell Lung Cancer Clinical Trial
Video Rating: 0 / 5
JVZoo Product Feed
GRACEcast-084_Lung-Cancer_ALK Inhibition: Science and Early Clinical Experience by Dr. Ben Solomon
cancergrace.org Dr. Ben Solomon of Peter MacCallum Cancer Centre in Melbourne Australia reviews ALK Inhibition from mechanism of action to activity and side effect profile of crizotinib, newly approved for patients with ALK-positive advanced non-small cell lung cancer.
Video Rating: 5 / 5
JVZoo Product Feed
Categories: Videos Tags: inhibition, solomon, clinical, science, gracecast084_lungcancer_alk, early, experience
Are there any clinical trials being done that could type and screen cancer samples to specific chemotherapies?
Question by Dks97: Are there any clinical trials being done that could type and screen cancer samples to specific chemotherapies?
Sort of like how blood is typed and screened. If a patient knew how their cells reacted to a specific regimen, it would save time going down a long list of chemotherapies. If a sample is taken and tested before chemo is scheduled to start, a patient could go right to that specific drug match and benefit. My mother has breast cancer and is on her 3rd drug combo. We keep going down a list of compatible drugs for her cancer type not knowing which will be a good long term match for her.
Best answer:
Answer by bmac
Here is the clinical trials site.
http://www.clinicaltrials.gov/
What do you think? Answer below!
JVZoo Product Feed
Categories: News Tags: trials, samples, there, done, cancer, specific, clinical, being, type, screen
Dr. Edwin Silverman talks about COPDGene and importance of clinical research participation
In this video—presented by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health—NHLBI grantee Dr. Edwin Silverman of Brigham and Women’s Hospital in Boston talks about COPD Gene, which he runs with Dr. James Crapo of National Jewish Health in Denver, and about the importance of participation in clinical studies. COPD Gene is a study of more than 10000 volunteers across the country who are undergoing genetic assessment, state-of-the-art CAT scan imaging, breathing tests and other measurements in order to better understand why some people get COPD (chronic obstructive pulmonary disease) and others don’t. The goal is to identify the genes that play a role in the development of COPD and to ultimately improve the prediction, diagnosis, and treatment of the disease. “This research would not have been possible without the incredible support from the general population,” said Dr. Silverman. “If we hadn’t had enthusiastic support from our volunteers who gave up their own time to come in, get a CAT scan, go through an extensive array of tests with breathing tests and walk tests and a long list of questionnaires, if they hadn’t been willing to do that, we just couldn’t do the work. “So I think that people need to understand that medical research isn’t something that happens out there by other people. If they want new medical discoveries, they should really consider getting involved. They should consider being part of clinical trials, consider …
Video Rating: 5 / 5
JVZoo Product Feed
Categories: Videos Tags: talks, importance, research, silverman, about, copdgene, participation, clinical, edwin
Advocacy in Action: Role of Global Advocate Community in Research & Clinical Trials
This discussion is led by Prof. David Kerr (President of ESMO), Diane Blum (CEO Lymphoma Research Foundation) Regina Vidaver (Exec. Dir. of the Nat’l Lung Cancer Partnership) and Selma Schimmel (Founder & CEO Vital Options International. Featuring Cancer Advocates: Arin Assero (International Myeloma Foundation), Andrea Evans (Y-Me National Breast Cancer Foundation) and Kim Ryan (Fight Colorectal Cancer).
Video Rating: 0 / 5
JVZoo Product Feed
Categories: Videos Tags: trials, community, research, role, action, advocate, global, advocacy, clinical
Young TIL Clinical Trial – Immunotherapy Program Milwaukee
VISIT WWW.THEIDEARAISER.COM FOR MORE INFORMATION Milwaukee is one of a few places in the world offering the Young TIL Clinical Trial. This treatment is providing amazing hope to patients suffering from melanoma, a form of cancer that kills thousands of people annually. Further, the research being done right here in Milwaukee holds exciting potential for other types of cancers. A patient suffering from stage four melanoma, who is otherwise fairly healthy but hasn’t responded to first level treatments including Interleukin 2, is assessed through a prescreening process to participate in the FDA cleared, Young TIL clinical research trial. In a nutshell, the Young TIL cell (or tumor infiltrating lymphocytes) are an army created from the patient’s own immune cells…those cells that can kill the cancer. this is a good treatment, it’s a new era, it’s a new world, it’s custom designed, it’s personalized, it’s your cells doing the job. And it may open the door in the same way that radiation therapy did and the same way chemotherapy did, and I’m convinced that this type of interesting and complex manipulation of the immune system is going to blow it open even more so.” — Dr. John Hanson Patient Testimonial “This is about a revolutionary treatment that can help cancer patients.” “It is an experiment, it is a trial, but guess what. It’s workin. And it’s workin incredibly well for patients like myself and others” — Jeff, Patient
JVZoo Product Feed
Why are clinical trials important for early detection research?
Simone Marticke, PhD, Canary Foundation Scientific Program Manager, explains the purpose of clinical trials and how they impact early cancer detection research. To learn more about the Canary Center at Stanford, visit: www.canaryfoundation.org/canary-center
Video Rating: 0 / 5
JVZoo Product Feed
Dr. Reckamp on Current Heat Shock Protein Clinical Trials
Karen Reckamp, MD, MS, assistant professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, California, describes the various clinical studies currently underway examining the use of heat shock proteins. Clinical trials are currently looking specifically at ALK translocated, crizotinib resistance, and patient that have not yet received crizotinib. Further examination is being completed into heat shock proteins in combination with docetaxel and other targets and biomarkers that specify which patients will have the most benefit.
Video Rating: 0 / 5
JVZoo Product Feed
Management of IPF: Recent Advances in Prognosis, Co-Morbidities and Clinical Trials Part 1 of 10
Presentation by Imre Noth, MD, Associate Professor of Medicine at the University of Chicago for the 2009 Pulmonary Fibrosis Symposium at St. Mary’s Medical Center in Evansville, Indiana. Part 1 of 10.
Video Rating: 0 / 5
Savannah Aulger will never have snapshots with her father on her first birthday, on Christmas or at a school event. The only picture she will ever have of them is the one as sweet as it is heartbreaking. Hooked up to an oxygen mask at the hospital, the man she would call dad cradled her in his arms for 45 minutes. He sobbed. He smiled. And there was no doubt that he loved her. “He would talk to my stomach when I was pregnant,” Diane Aulger said of her husband. “He was so excited for her.” The next day, Mark Aulger slipped into a coma. The Aulger family of The Colony, Texas, had a lot to rejoice about in the weeks before Savannah’s Jan. 18 birth, which was induced two weeks early so her father could hold her. A home movie on Christmas showed a pregnant Diane Aulger, 31, handing out gifts to their four children, the oldest of whom is 15. Mark, 52, who had just received the news that he had beaten cancer, played the guitar, providing a soundtrack for the Christmas morning festivities. On Jan. 3, life threw a curveball. ABC News Diane Aulger induced labor so her dying… View Full Size Homeless Man’s Dying Wish: Dog Reunion Watch Video Dying Man Gets Wish for Citizenship Watch Video Dying Boy Meets Santa Watch Video Mark Aulger was admitted to the hospital, unable to breathe. Doctors told him that eight months of chemotherapy had ravaged his lungs and diagnosed him with pulmonary fibrosis. “We thought he could get on steroid treatment and oxygen and live for years,” Diane …
JVZoo Product Feed
Categories: Videos Tags: management, prognosis, recent, advances, trials, part, clinical, comorbidities
Gastric Emphysema: Causes, Clinical Implications, and CT Findings.
Gastric Emphysema: Causes, Clinical Implications, and CT Findings.
Video Rating: 5 / 5
JVZoo Product Feed
